Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease multiple system atrophy
Comorbidity C0030567|parkinson\'s disease
Sentences 7
PubMedID- 25745454 Another study found significantly increased levels of nf-l and nf-h in parkinson's disease with multiple system atrophy and various protein labeling[78].
PubMedID- 23815045 Objectives: we sought to compare the laryngeal symptoms of parkinson's disease (pd) with those of multiple system atrophy (msa), a parkinson-plus syndrome; to review the differences in surgical management of upper airway dysfunction between patients with pd and those with msa; and to present a treatment algorithm for management of upper airway disorders in patients with pd and msa.
PubMedID- 22102521 There was a trend for greater asymmetry of striatal binding in multiple system atrophy compared with parkinson's disease (23% +/- 15% vs 10.5% +/- 7%, respectively; p = .071), with 3 multiple system atrophy patients showing more asymmetry of striatal binding than any parkinson's disease patient.
PubMedID- 23525968 multiple system atrophy (msa) together with parkinson's disease belongs to a diverse group of neurodegenerative conditions termed alpha-synucleinopathies.
PubMedID- 24355363 Sensorimotor gating deficits in multiple system atrophy: comparison with parkinson's disease and idiopathic rem sleep behavior disorder.
PubMedID- 22888453 The α-synuclein dysfunction is the critical pathogenic event in parkinson's disease that leads to multiple system atrophy and dementia with lewy bodies [167, 169].
PubMedID- 24940065 The diagnoses were: parkinson's disease with dementia, multiple system atrophy parkinsonian type, multiple system atrophy cerebellar type, progressive supranuclear palsy, corticobasal degeneration, lewy body dementia, and frontotemporal dementia with parkinsonism.

Page: 1